Cerenkov luminescence imaging is an effective preclinical tool for assessing colorectal cancer PD-L1 levels in vivo

BACKGROUND: Preclinical and clinical studies have demonstrated that immunotherapy has effectively delayed tumor progression, and the clinical outcomes of anti-PD-1/PD-L1 therapy were related to PD-L1 expression level in the tumors. A (131)I-labeled anti-PD-L1 monoclonal antibody tracer, (131)I-PD-L1...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhao, Sheng, Pan, Wenbin, Jiang, Huijie, Zhang, Rongjun, Jiang, Hao, Liang, Zonghui, Hu, Hongbo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7295871/
https://www.ncbi.nlm.nih.gov/pubmed/32542442
http://dx.doi.org/10.1186/s13550-020-00654-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7295871/
https://www.ncbi.nlm.nih.gov/pubmed/32542442
http://dx.doi.org/10.1186/s13550-020-00654-w

Ejemplares similares